Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 44 citing articles:

Forkhead Transcription Factors in Health and Disease
Laetitia Herman, Anne‐Laure Todeschini, Reiner A. Veitia
Trends in Genetics (2020) Vol. 37, Iss. 5, pp. 460-475
Closed Access | Times Cited: 95
Problems of glioblastoma multiforme drug resistance
A. A. Stavrovskaya, С. С. Шушанов, Ekaterina Yu. Rybalkina
Biochemistry (Moscow) (2016) Vol. 81, Iss. 2, pp. 91-100
Closed Access | Times Cited: 89
Akt Pathway Inhibitors
Nne E. Uko, Osman Güner, Diane F. Matesic, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 10, pp. 883-900
Closed Access | Times Cited: 86
Cytoprotection “gone astray’’: Nrf2 and its role in cancer
H. Schäfer, Claudia Geismann, Alexander Arlt, et al.
OncoTargets and Therapy (2014), pp. 1497-1497
Open Access | Times Cited: 80
Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells
Sara Häggblad Sahlberg, Anja C. Mortensen, Jakob Haglöf, et al.
International Journal of Oncology (2016) Vol. 50, Iss. 1, pp. 5-14
Open Access | Times Cited: 63
Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis
Ciric To, Carol S. Ringelberg, Darlene B. Royce, et al.
Carcinogenesis (2015) Vol. 36, Iss. 7, pp. 769-781
Open Access | Times Cited: 60
Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways
Jie Liu, Wei Huang, Caiping Ren, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 49
2α-Hydroxyalantolactone from Pulicaria undulata: activity against multidrug-resistant tumor cells and modes of action
Mohamed‐Elamir F. Hegazy, Mona Dawood, Nuha Mahmoud, et al.
Phytomedicine (2020) Vol. 81, pp. 153409-153409
Closed Access | Times Cited: 35
Akt1 Stimulates Homologous Recombination Repair of DNA Double-Strand Breaks in a Rad51-Dependent Manner
Katharina Mueck, Simone Rebholz, Mozhgan Dehghan Harati, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 11, pp. 2473-2473
Open Access | Times Cited: 39
Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells
Ilaria Guerriero, Daniela D’Angelo, Pierlorenzo Pallante, et al.
Oncotarget (2016) Vol. 8, Iss. 12, pp. 19172-19191
Open Access | Times Cited: 33
Preclinical Efficacy and Involvement of AKT, mTOR, and ERK Kinases in the Mechanism of Sulforaphane against Endometrial Cancer
Rajani Rai, K.G. Essel, Doris M. Benbrook, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1273-1273
Open Access | Times Cited: 28
Chlorogenic acid attenuates idiopathic pulmonary fibrosis: An integrated analysis of network pharmacology, molecular docking, and experimental validation
Juan Manuel Velázquez-Enríquez, Jovito Cesar Santos-Álvarez, Alma Aurora Ramírez-Hernández, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 734, pp. 150672-150672
Closed Access | Times Cited: 3
Protein kinase B
Bhumika Wadhwa, Ubaid Makhdoomi, Ram A. Vishwakarma, et al.
Anti-Cancer Drugs (2017) Vol. 28, Iss. 6, pp. 569-580
Closed Access | Times Cited: 31
Distinct Profiles for Mitochondrial t-RNAs and Small Nucleolar RNAs in Locally Invasive and Metastatic Colorectal Cancer
Lai Xu, Joseph M. Ziegelbauer, Rong Wang, et al.
Clinical Cancer Research (2015) Vol. 22, Iss. 3, pp. 773-784
Open Access | Times Cited: 30
Effect of evodiagenine mediates photocytotoxicity on human breast cancer cells MDA-MB-231 through inhibition of PI3K/AKT/mTOR and activation of p38 pathways
Changliang Xu, Qizhi Wang, Xu Feng, et al.
Fitoterapia (2014) Vol. 99, pp. 292-299
Open Access | Times Cited: 29
Akt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppression
Marion Le Grand, Raphaël Bergès, Eddy Pasquier, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 27
Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling
Haijing Wang, Zaixing Yang, Xiaotian Dai, et al.
APOPTOSIS (2017) Vol. 22, Iss. 9, pp. 1157-1168
Closed Access | Times Cited: 27
Unique roles ofAkt1andAkt2in IGF-IR mediated lung tumorigenesis
S. Elizabeth Franks, Ritesh Briah, Robert A. Jones, et al.
Oncotarget (2015) Vol. 7, Iss. 3, pp. 3297-3316
Open Access | Times Cited: 26
The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy
Shengyan Xi, Ying Peng, Gerald Y. Minuk, et al.
Journal of Ethnopharmacology (2016) Vol. 190, pp. 1-12
Closed Access | Times Cited: 24
Decreased expression of nucleophosmin/B23 increases drug sensitivity of adriamycin-resistant Molt-4 leukemia cells through mdr-1 regulation and Akt/mTOR signaling
Lingyan Wang, Buyuan Chen, Minhui Lin, et al.
Immunobiology (2014) Vol. 220, Iss. 3, pp. 331-340
Closed Access | Times Cited: 24
MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability
Hongkai Zhang, Yin Cheng, Congwei Jia, et al.
Medical Oncology (2014) Vol. 32, Iss. 1
Closed Access | Times Cited: 23
Fucoxanthin prevents cell growth and induces apoptosis in endometrial cancer HEC‐1A cells by the inhibition of the PI3K/Akt/mTOR pathway
Jinfeng Qu, Ya‐Ping Sun, Lukai Yang, et al.
Journal of Biochemical and Molecular Toxicology (2022) Vol. 36, Iss. 6
Closed Access | Times Cited: 12
Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study
Eric Angevin, Philippe A. Cassier, Antoîne Italiano, et al.
European Journal of Cancer (2017) Vol. 83, pp. 194-202
Closed Access | Times Cited: 15
Ultrasound assisted one-pot synthesis of rosuvastatin based novel azaindole derivatives via coupling–cyclization strategy under Pd/Cu-catalysis: Their evaluation as potential cytotoxic agents
J.S. Dileep Kumar, Gangireddy Sujeevan Reddy, Raghavender Medishetti, et al.
Bioorganic Chemistry (2022) Vol. 124, pp. 105857-105857
Closed Access | Times Cited: 8
MiR-495/IGF-1/AKT Signaling as a Novel Axis Is Involved in the Epithelial-to-Mesenchymal Transition of Oral Squamous Cell Carcinoma
Yong Wang, Jia Li, Bin Wang, et al.
Journal of Oral and Maxillofacial Surgery (2019) Vol. 77, Iss. 5, pp. 1009-1021
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top